Cargando…
Aging in HIV-Infected Subjects: A New Scenario and a New View
The prevalence of HIV-infected people aged 50 years or older is increasing rapidly; the proportion will increase from 28% to 73% in 2030. In addition, HIV-infected individuals may be more vulnerable to age-related condition. There is growing evidence that the prevalence of comorbidities and other ag...
Autores principales: | Negredo, Eugenia, Back, David, Blanco, José-Ramón, Blanco, Julià, Erlandson, Kristine M., Garolera, Maite, Guaraldi, Giovanni, Mallon, Patrick, Moltó, José, Serra, José Antonio, Clotet, Bonaventura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753008/ https://www.ncbi.nlm.nih.gov/pubmed/29430462 http://dx.doi.org/10.1155/2017/5897298 |
Ejemplares similares
-
Antiretroviral Simplification with Darunavir/Ritonavir Monotherapy in Routine Clinical Practice: Safety, Effectiveness, and Impact on Lipid Profile
por: Santos, José R., et al.
Publicado: (2012) -
Classification Models for Neurocognitive Impairment in HIV Infection Based on Demographic and Clinical Variables
por: Muñoz-Moreno, Jose A., et al.
Publicado: (2014) -
Transdermal rivastigmine for HIV-associated cognitive impairment: A randomized pilot study
por: Muñoz-Moreno, Jose A., et al.
Publicado: (2017) -
A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV
por: Negredo, Eugènia, et al.
Publicado: (2020) -
Randomised Study to Assess the Efficacy and Safety of Once-Daily Etravirine-Based Regimen as a Switching Strategy in HIV-Infected Patients Receiving a Protease Inhibitor–Containing Regimen. Etraswitch Study
por: Echeverría, Patricia, et al.
Publicado: (2014)